News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ViRexx Medical Corp. (VIR.V) Receives Delisting Notification From AMEX Regarding Non-Compliance With Listing Standards


8/29/2008 9:44:19 AM

EDMONTON, ALBERTA--(Marketwire - August 28, 2008) - ViRexx Medical Corp. (TSX: VIR) (AMEX: REX), a company focused on developing innovative-targeted therapeutic products that offer better quality of life and a renewed hope for living. Its platform technologies include product candidates for the treatment of Hepatitis B, Hepatitis C, avian influenza viral infections, biodefence and nanoparticle applications, select solid tumors and late-stage ovarian cancer, received notification from the American Stock Exchange ("AMEX" or "Exchange") that the Company's plan to regain compliance with ongoing listing standards of the AMEX was not accepted and intends to initiate the delisting process unless the Company submits an appeal by August 29, 2008.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES